Entry |
|
Name |
Opigolix (USAN/INN) |
Formula |
C25H19F3N4O5S
|
Exact mass |
544.1028
|
Mol weight |
544.50
|
Structure |
|
Efficacy |
Anti-endometriosis, Gonadotropin-releasing hormone receptor antagonist |
Comment |
Treatment of endometriosis
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Gonadotropin-releasing hormone
GNRHR
D11351 Opigolix (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 38
1 C5a C 16.4500 -20.9300
2 C2c C 17.6624 -21.6300
3 C5a C 18.8579 -20.9396
4 O5a O 15.2376 -21.6300
5 C8y C 16.4500 -19.5300
6 C8x C 17.6624 -18.8300
7 C8y C 17.6624 -17.4300
8 C8x C 16.4500 -16.7300
9 C8x C 15.2376 -17.4300
10 C8y C 15.2376 -18.8300
11 X F 18.8579 -16.7396
12 X F 14.0421 -19.5204
13 C8y C 17.6625 -23.0298
14 C8y C 20.0453 -21.6251
15 O5a O 18.8580 -19.5303
16 C8x C 20.0454 -23.0298
17 C8x C 21.2579 -23.7297
18 C8y C 22.4703 -23.0296
19 C8y C 22.4701 -21.6249
20 C8x C 21.2576 -20.9250
21 X F 23.6828 -23.7294
22 S4a S 23.6802 -20.9261
23 N1b N 24.8791 -21.6183
24 C2c C 26.0646 -20.9338
25 C1c C 27.2569 -21.6222
26 N2a N 26.0647 -19.5302
27 C1a C 28.4458 -20.9358
28 O1a O 27.2570 -23.0297
29 O3c O 24.3802 -19.7137
30 O3c O 22.6902 -19.9362
31 N4x N 16.5153 -23.8636
32 C8y C 16.9538 -25.2124
33 C8y C 18.3720 -25.2122
34 N4x N 18.8101 -23.8633
35 C8x C 16.2540 -26.4250
36 C8x C 16.9542 -27.6373
37 C8x C 18.3724 -27.6371
38 C8x C 19.0722 -26.4245
BOND 41
1 1 2 1
2 2 3 1
3 1 4 2
4 1 5 1
5 5 6 2
6 6 7 1
7 7 8 2
8 8 9 1
9 9 10 2
10 5 10 1
11 7 11 1
12 10 12 1
13 2 13 2
14 3 14 1
15 3 15 2
16 14 16 2
17 16 17 1
18 17 18 2
19 18 19 1
20 19 20 2
21 14 20 1
22 18 21 1
23 19 22 1
24 22 23 1
25 23 24 1
26 24 25 1
27 24 26 2
28 25 27 1
29 25 28 1 #Up
30 22 29 2
31 22 30 2
32 13 31 1
33 31 32 1
34 32 33 1
35 33 34 1
36 13 34 1
37 32 35 2
38 35 36 1
39 36 37 2
40 37 38 1
41 33 38 2
|